Hint mode is switched on Switch off
For swift navigation between sections

Bridgebio Pharma Bonds, 2.25% 1feb2029, USD (Conv.) (FIGI BBG00Z1G6G03, WKN A3K1NF)

Download
Copy issue information to clipboard
Copy issue information to clipboard
Copy to clipboard
Data copied to the clipboard

PDF download

Choose all Reset all
Download Cancel

FIND, SAVE & TRACK INVESTMENTS WITH CBONDS WATCHLIST

With Cbonds Watchlist you can always stay updated on your investments to make conscious decisions!

Watchlist
You need to request access

Domestic bonds, Convertible, Trace-eligible, Senior Unsecured

Status
Outstanding
Amount
747,500,000 USD
Placement
***
Redemption (put/call option)
*** (-)
ACI
Country of risk
USA
Current coupon
***%
Price
Yield / Duration
  • Placement amount
    747,500,000 USD
  • Outstanding amount
    747,500,000 USD
  • USD equivalent
    747,500,000 USD
  • Face value
    1,000 USD
  • CFI
    DCFNGR
  • FIGI
    BBG00Z1G6G03
  • SEDOL
    2H0XMP5
  • Ticker
    BBIO 2.25 02/01/29
Cbonds API

Get Financial Data Automatically via API

Receive pricing and descriptive data for

  • Bonds
  • Stocks
  • Indices
  • ETFs
  • Funds
  • Global data coverage: Descriptive data, Prices, cash flow, bond prospectuses, IFRS reports
  • Easy Integration: API • Data Feeds • Web Services
  • Transparent Pricing: Tailored to your needs
Free Plan

Start exploring global markets in less than 1 minute

  • 100,000+ Stocks
  • 17,000+ ETFs
  • 150,000+ Mutual Funds
  • Global Macro & Commodity Data
  • Research Hub & Basic Market News
  • AI Bond Screener
Free Plan
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Unlock data Watch full tour

Trading chart

Stock exchange selection
Stock exchange selection
More about Cbonds Estimation
No more than two exchanges can be selected for comparison at the same time
Data display in a chart | table
Data display in a chart | table
Work with the chart: switching the price, period, issue comparison
Work with the chart: switching the price, period, issue comparison
Customize fields in the table
Found:
Show all fields
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
* Data is not available within the selected subscription

Explore the most comprehensive database

1 000 000

bonds

100 000

stocks

175 910

ETF & Funds

100 000

indices

Track your portfolio in the most efficient way

  • Bond Search
  • Watchlist
  • Excel ADD-IN
Get access
×

— Are you looking for the complete & verified bond data?

— We have everything you need:

full data on over 1 000 000 bonds, 100 000 stocks, 100 000 indices, 17 000 ETF and 150 000 Mutual Funds; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.

Register
×

Why

You will have detailed descriptive & pricing data for 1M bonds, 100K stocks, 100K indices, 17K ETF and 150K Mutual Funds
Get full access to the platform from any device & via Cbonds app
Enhance your portfolio management with Cbonds Excel Add-in
Build yield maps, make chart comparison within a click
Don't wait any longer — start using Cbonds today! Register

Issue information

Profile
Bridgebio Pharma, Inc. operates as a bio technology company. The company focuses on development of medicines for genetic diseases. It was founded in 2015.
Research report by Cbonds-PRAAMS Save
Authorization required
Report download is available only paid Premium subscription access
Volume
  • Placement amount
    747,500,000 USD
  • Outstanding amount
    747,500,000 USD
  • Outstanding face value amount
    747,500,000 USD
Face value
  • Minimum Settlement Amount
    1,000 USD
  • Face value
    1,000 USD
  • Outstanding face value
    *** USD
  • Increment
    *** USD

Get access to the largest bond database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest bond database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Cash flow parameters

  • Reference rate
    ***
  • Coupon Rate
    ***
  • Day count convention
    ***
  • Interest Accrual Date
    ***
  • Coupon frequency
    *** time(s) per year
  • Payment currency
    ***
  • Maturity date
    ***

Cash flow

Export to Excel

Early redemption terms

***

Explore the most comprehensive database

1 000 000

bonds

100 000

stocks

175 910

ETF & Funds

100 000

indices

Track your portfolio in the most efficient way

  • Bond Search
  • Watchlist
  • Excel ADD-IN
Get access
×

— Are you looking for the complete & verified bond data?

— We have everything you need:

full data on over 1 000 000 bonds, 100 000 stocks, 100 000 indices, 17 000 ETF and 150 000 Mutual Funds; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.

Register
×

Why

You will have detailed descriptive & pricing data for 1M bonds, 100K stocks, 100K indices, 17K ETF and 150K Mutual Funds
Get full access to the platform from any device & via Cbonds app
Enhance your portfolio management with Cbonds Excel Add-in
Build yield maps, make chart comparison within a click
Don't wait any longer — start using Cbonds today! Register

Placement

  • Placement method
    Closed subscription
  • Placement type
    Public
  • Placement
    ***
  • Initial issue price (yield)
  • Geographic breakdown
    ***
  • Investor breakdown
    ***
Participants
  • Bookrunner
    ***, ***, ***, ***, ***, ***, ***
  • Depository
    ***, ***

Conversion and exchange

  • Initial premium
    ***%
  • Convertible until
    ***
  • Conversion terms
    ***

Latest issues

Show all

Similar issues

News

17/08/2026 Bridgebio Pharma: Entry Into A Material Definitive Agreement, Other Events, Financial Statements And Exhibits
01/07/2026 Bridgebio Pharma: Entry Into A Material Definitive Agreement, Unregistered Sales Of Equity Securities, Material Modification To Rights Of Security Holders, Amendments To Articles Of Incorporation Or Bylaws; Change In Fiscal Year, Regulation Fd Disclosure, Financial Statements And Exhibits
26/06/2026 Bridgebio Pharma: Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Submission Of Matters To A Vote Of Security Holders, Financial Statements And Exhibits
08/05/2026 BridgeBio Pharma (NASDAQ:BBIO) Demonstrates Strong Growth and Positive Outlook
07/05/2026 Bridgebio Pharma: Entry Into A Material Definitive Agreement, Termination Of A Material Definitive Agreement, Financial Statements And Exhibits
All organization news

IFRS/US GAAP reports

2026
I q eng
II q eng
2025
I q eng
II q eng
III q eng
IV q eng
2024
I q eng
II q eng
III q eng
IV q eng
2023
I q eng
II q eng
III q eng
IV q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
I q eng
II q eng
III q eng
IV q eng
2020
I q eng
II q eng
III q eng
IV q eng
2019
II q eng
III q eng
IV q eng
Show more Hide
Authorization required
You need to request access

Identifiers

  • ISIN
    ***
  • Cbonds ID
    926473
  • ISIN temporary/additional
    US10806XAC65
  • CUSIP
    ***
  • CUSIP 144A
    ***
  • CFI
    DCFNGR
  • FIGI
    BBG00Z1G6G03
  • WKN
    A3K1NF
  • SEDOL
    2H0XMP5
  • Ticker
    BBIO 2.25 02/01/29
  • Type of security by CBR
    ***
Show more Hide

Bond classification

  • Senior Unsecured
  • Registered
  • Coupon bonds
  • Convertible
  • Trace-eligible
  • Amortization
  • Callable
  • CDO
  • Dual currency bonds
  • Variable rate
  • For qualified investors (CIS region)
  • Foreign bonds
  • Green bonds
  • Guaranteed
  • Inflation-linked principal
  • Supranational bond issues
  • Inflation-linked coupon
  • Mortgage bonds
  • Non-complex financial instruments (MiFID)
  • Perpetual
  • Payment-in-kind
  • Non-Marketable Securities
  • Redemption Linked
  • Restructuring
  • Retail bonds
  • Covered
  • Securitization
  • Structured product
  • Commercial Bonds
  • Subordinated
  • Sukuk
Show more Hide

Restructuring

***

Holders

Registration is required to get access.